Detailed Long-term Dynamics of Neutrophil-to-Lymphocyte Ratio under Biologic Treatment Reveals Differential Effects of Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists

Interleukin 12 ◽

Biologic Treatment ◽

Necrosis Factor Alpha ◽

Lymphocyte Ratio ◽

Factor Alpha ◽

P371 Short- and long-term efficacy of infliximab in intestinal Behcet's disease refractory to conventional medications indicates a major role for tumour necrosis factor-alpha

Journal of Crohn s and Colitis ◽

10.1016/s1873-9946(13)60392-x ◽

2013 ◽

Vol 7 ◽

pp. S158

Author(s):

H. Kinoshita ◽

R. Kunisaki ◽

S. Tomohiko ◽

H. Kimura ◽

S. Maeda

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Intestinal Behçet’S Disease ◽

Necrosis Factor Alpha ◽

Term Efficacy ◽

Short And Long Term ◽

Factor Alpha ◽

Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12

Immunology ◽

10.1111/j.1365-2567.2004.01856.x ◽

2004 ◽

Vol 112 (1) ◽

pp. 28-37 ◽

Cited By ~ 116

Author(s):

Laurence Guzylack-Piriou ◽

Carole Balmelli ◽

Kenneth C. McCullough ◽

Artur Summerfield

Keyword(s):

Tumour Necrosis Factor ◽

Interferon Alpha ◽

Tumour Necrosis ◽

Type A ◽

Interleukin 12 ◽

Necrosis Factor Alpha ◽

Cpg Oligonucleotides ◽

Factor Alpha ◽

Alterations in mononuclear cell tumour necrosis factor-alpha (TNF-a) response in patients on long term cuprophane haemodialysis

Clinical & Experimental Immunology ◽

10.1111/j.1365-2249.1992.tb05830.x ◽

2008 ◽

Vol 90 (1) ◽

pp. 49-55

Author(s):

A. Y. ANNENKOV ◽

A. G. STROKOV ◽

F. S. BARANOVA

Keyword(s):

Tumour Necrosis Factor ◽

Mononuclear Cell ◽

Tumour Necrosis ◽

Cell Tumour ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

E68. IMPACT OF ALTERNATIVE DEFINITIONS OF TREATMENT RESPONSE ON LONG-TERM EFFICACY OF SECUKINUMAB IN TUMOUR NECROSIS FACTOR-ALPHA–NAÏVE PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS

Rheumatology ◽

10.1093/rheumatology/kex063.067 ◽

2017 ◽

Vol 56 (suppl_2) ◽

Author(s):

Helena Marzo-Ortega ◽

Anna Halliday ◽

Steffen Jugl ◽

Soniya Mokashi ◽

Brian Porter ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Treatment Response ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Term Efficacy ◽

Factor Alpha ◽

220. Predicting Successful Long-Term Treatment with Tumour Necrosis Factor Alpha Inhibitors in Patients with Psoriatic Arthritis

Rheumatology ◽

10.1093/rheumatology/kev089.107 ◽

2015 ◽

Keyword(s):

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Term Treatment ◽

Necrosis Factor Alpha ◽

Long Term Treatment ◽

Factor Alpha ◽

Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease

Gut ◽

10.1136/gut.50.2.196 ◽

2002 ◽

Vol 50 (2) ◽

pp. 196-200 ◽

Cited By ~ 88

Author(s):

J Bauditz

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Interleukin 12 ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Tumour necrosis factor-alpha is a fundamental cytokine in autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide in interleukin-12 p40 deficient C57BL/6 mice

Immunology ◽

10.1046/j.1365-2567.2003.01547.x ◽

2003 ◽

Vol 108 (1) ◽

pp. 50-54 ◽

Cited By ~ 10

Author(s):

Paola Zaccone ◽

Zoltan Fehervari ◽

Anne Cooke

Keyword(s):

Tumour Necrosis Factor ◽

Thyroid Disease ◽

Tumour Necrosis ◽

Autoimmune Thyroid Disease ◽

Interleukin 12 ◽

Necrosis Factor Alpha ◽

Autoimmune Thyroid ◽

Factor Alpha ◽

Does anti-tumour necrosis factor alpha therapy exert a long-term structural benefit in hand osteoarthritis?

Rheumatology ◽

10.1093/rheumatology/key210 ◽

2018 ◽

Author(s):

Jorge A Roman-Blas ◽

Helen Keen ◽

Gabriel Herrero-Beaumont

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Hand Osteoarthritis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Alpha Therapy ◽

Combined inhibition of tumour necrosis factor-alpha and interleukin-12/23 for long-standing, refractory psoriatic disease: a differential role for cytokine pathways?

Rheumatology ◽

10.1093/rheumatology/key199 ◽

2018 ◽

Vol 57 (11) ◽

pp. 2053-2055

Author(s):

Gabriele De Marco ◽

Dennis McGonagle ◽

Hannah R Mathieson ◽

Mira Merashli ◽

Conor Magee ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Interleukin 12 ◽

Necrosis Factor Alpha ◽

Psoriatic Disease ◽

Factor Alpha ◽

Circulating complexes between tumour necrosis factor‐alpha and etanercept predict long‐term efficacy of etanercept in juvenile idiopathic arthritis

Acta Paediatrica ◽

10.1111/apa.13319 ◽

2016 ◽

Vol 105 (4) ◽

pp. 427-432 ◽

Cited By ~ 10

Author(s):

Robin Kahn ◽

Elisabet Berthold ◽

Birgitta Gullstrand ◽

Tobias Schmidt ◽

Fredrik Kahn ◽

...

Keyword(s):

Juvenile Idiopathic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Term Efficacy ◽

Factor Alpha ◽